Wyr.ai Partners with Vuzix to Launch Its New M400 Smart Glasses-based AI-driven Quality Assurance Inspection Platform — Neutral
VUZI PRNewsWire — June 03, 2025ROCHESTER, N.Y. , June 3, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of AI-powered smart glasses, waveguides and Augmented Reality (AR) technologies, today announced that the Company and Wyr.ai Private Limited ("Wyr.ai"), a trailblazing XR and AI product company that revolutionizes industries through cutting-edge technology, have partnered to launch a new AI-driven quality assurance inspection platform that uses Vuzix M400™ smart glasses.

Science Applications Stock Plunges 13% as Q1 Earnings Miss Estimates — Negative
SAIC Zacks Investment Research — June 03, 2025SAIC stock declines 13% after Q1 earnings miss, flat profits and margin pressure weigh despite modest revenue growth.

Hilton Fuels Luxury Growth With New Brands and 500 Hotels Pipeline — Neutral
HLT Zacks Investment Research — June 03, 2025HLT hits 1,000 luxury hotels, adds new brands and global partnerships, with 500 more in its upscale pipeline.

Tims China Registration & Webcast details for Q1 2025 Results Conference Call on June 24, 2025 — Neutral
THCH GlobeNewsWire — June 03, 2025SHANGHAI, and NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- TH International Limited (“Tims China” (Nasdaq: THCH)), the exclusive operator of Tim Hortons coffee shops in China, plans to release its first quarter results before market opening on Tuesday June 24, 2025, with a conference call to follow at 8:00 AM EST or 8:00 PM China Standard Time. The conference call will be webcast, and can be accessed on the company website at https://ir.timschina.com/events-presentations/presentations-webcasts.

Marlton Partners Calls on 180 Degree Capital Corp. to Set Record Date Now and Allow Shareholders to Determine Company's Future — Neutral
TURN PRNewsWire — June 03, 2025Issues Letter to TURN Shareholders Detailing Continued Governance Failures and Mismanagement by 180 Board and Management Team CHICAGO , June 3, 2025 /PRNewswire/ -- Marlton Partners L.P. (together with its affiliates and group members, "Marlton" or "we"), beneficial owners of approximately 5.2% of the outstanding stock of 180 Degree Capital Corp. (NASDAQ: TURN) (the "Company"), today issued an open letter calling on the TURN Board of Directors to immediately set a record date and allow shareholders to vote on the Company's proposed sale to Mount Logan Capital Inc. (Cboe Canada: MLC) ("Mount Logan"): Dear Fellow Shareholders of 180 Degree Capital …

Class Action Lawsuit Filed: Viatris Inc. (VTRS) - Join by June 3, 2025 - Contact Levi & Korsinsky — Neutral
VTRS Accesswire — June 03, 2025NEW YORK, NY / ACCESS Newswire / June 3, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=151460&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.

Meta inks nuclear deal with Constellation Energy under 20-year agreement — Positive
CEG META CNBC Television — June 03, 2025CNBC's Pippa Stevens reports on news regarding Meta.

Hold Onto Your Cocktail: Captain Morgan and Universal Pictures' M3GAN 2.0 Join Forces with a Glow-in-the-Dark Spiced Rum Bottle and Limited-Edition Cocktail Experience — Neutral
DEO PRNewsWire — June 03, 2025Get ready to slay summer. NEW YORK , June 3, 2025 /PRNewswire/ -- Captain Morgan is joining forces with the ultimate queen of chaos, M3GAN, for a summer collab that's serving spice, sass, and serious main character energy.

Should You Invest in Nice (NICE) Based on Bullish Wall Street Views? — Positive
NICE Zacks Investment Research — June 03, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Wall Street Analysts Think Microsoft (MSFT) Is a Good Investment: Is It? — Neutral
MSFT Zacks Investment Research — June 03, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Is It Worth Investing in Booking Holdings (BKNG) Based on Wall Street's Bullish Views? — Positive
BKNG Zacks Investment Research — June 03, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Wall Street Bulls Look Optimistic About Zscaler (ZS): Should You Buy? — Positive
ZS Zacks Investment Research — June 03, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Is Archrock Inc. (AROC) a Buy as Wall Street Analysts Look Optimistic? — Positive
AROC Zacks Investment Research — June 03, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Brokers Suggest Investing in Diversified Energy Company PLC (DEC): Read This Before Placing a Bet — Negative
DEC Zacks Investment Research — June 03, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Brokers Suggest Investing in Progressive (PGR): Read This Before Placing a Bet — Negative
PGR Zacks Investment Research — June 03, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Wall Street Analysts Think MINISO Group Holding Limited (MNSO) Is a Good Investment: Is It? — Positive
MNSO Zacks Investment Research — June 03, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Wall Street Analysts See Allegheny Technologies (ATI) as a Buy: Should You Invest? — Negative
ATI Zacks Investment Research — June 03, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Lam Research (LRCX) Just Overtook the 20-Day Moving Average — Positive
LRCX Zacks Investment Research — June 03, 2025After reaching an important support level, Lam Research (LRCX) could be a good stock pick from a technical perspective. LRCX surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.

Down 54.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Omeros (OMER) — Positive
OMER Zacks Investment Research — June 03, 2025Omeros (OMER) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Down 36.7% in 4 Weeks, Here's Why Summit Therapeutics (SMMT) Looks Ripe for a Turnaround — Positive
SMMT Zacks Investment Research — June 03, 2025Summit Therapeutics (SMMT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
